Jan. 25, 2016 – The Office of Prescription Drug Promotion (OPDP) kicked off 2016 with a Jan. 14 Untitled Letter to Hospira Inc., a Pfizer company, citing a video posted on YouTube that presents information about what to expect from Hospira’s Precedex™. OPDP states in the letter that the video “is false or misleading because […]
Read more